Does CVS Caremark cover Zepbound or Wegovy?
Last updated
Only if your plan sponsor covers weight-loss drugs; Zepbound is preferred again.
If it is not covered: the lowest cash prices now

Without insurance: compounded tirzepatide on a monthly plan, not FDA-approved
$69/mo + $199/yr membership · about $86 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before

Without insurance: compounded semaglutide on a monthly plan, not FDA-approved
$59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before
Only if your plan sponsor covers weight-loss drugs; Zepbound is preferred again. CVS Caremark added Zepbound back to its commercial formularies as an additional preferred option on October 1, 2026, for plan sponsors that elect to cover these drugs. In its words: "CVS Caremark will add Zepbound back to our commercial formularies as an additional preferred option October 1, 2026, increasing access to GLP-1s at a more affordable price for plan sponsors who elect to provide coverage of those medications for their members." (CVS Health press release, CVS Caremark delivers affordability and access to GLP-1 weight management medications with expanded coverage options, May 28, 2026, cvshealth.com, read Nov 17, 2026). Plan sponsors that use CVS Caremark's template formularies can still customize what they cover. In its words: "Plan sponsors that adopt CVS Caremark template formularies retain discretion to customize coverage for their members." (CVS Health press release, CVS Caremark delivers affordability and access to GLP-1 weight management medications with expanded coverage options, May 28, 2026, cvshealth.com, read Nov 17, 2026). CVS Caremark preferred Wegovy and removed Zepbound from its commercial template formularies on July 1, 2025. In its words: "to prefer Wegovy and remove Zepbound. We’re confident our decision to prefer Wegovy on our commercial template formularies will enable wider, more affordable coverage for weight management drugs, while preserving clinical integrity." (CVS Health, Improving access and affordability to high-cost weight management drugs, June 27, 2025, cvshealth.com, read Nov 17, 2026).
CVS Caremark, Zepbound and Wegovy: common questions
Does CVS Caremark cover Zepbound for weight loss?
Only if your plan sponsor covers weight-loss drugs; Zepbound is preferred again. CVS Caremark added Zepbound back to its commercial formularies as an additional preferred option on October 1, 2026, for plan sponsors that elect to cover these drugs. In its words: "CVS Caremark will add Zepbound back to our commercial formularies as an additional preferred option October 1, 2026, increasing access to GLP-1s at a more affordable price for plan sponsors who elect to provide coverage of those medications for their members." (CVS Health press release, CVS Caremark delivers affordability and access to GLP-1 weight management medications with expanded coverage options, May 28, 2026, cvshealth.com, read Nov 17, 2026). Plan sponsors that use CVS Caremark's template formularies can still customize what they cover. In its words: "Plan sponsors that adopt CVS Caremark template formularies retain discretion to customize coverage for their members." (CVS Health press release, CVS Caremark delivers affordability and access to GLP-1 weight management medications with expanded coverage options, May 28, 2026, cvshealth.com, read Nov 17, 2026). CVS Caremark preferred Wegovy and removed Zepbound from its commercial template formularies on July 1, 2025. In its words: "to prefer Wegovy and remove Zepbound. We’re confident our decision to prefer Wegovy on our commercial template formularies will enable wider, more affordable coverage for weight management drugs, while preserving clinical integrity." (CVS Health, Improving access and affordability to high-cost weight management drugs, June 27, 2025, cvshealth.com, read Nov 17, 2026). Zepbound not covered: the cash price at your dose
Does CVS Caremark cover Wegovy for weight loss?
Only if your plan sponsor covers weight-loss drugs; Zepbound is preferred again. CVS Caremark added Zepbound back to its commercial formularies as an additional preferred option on October 1, 2026, for plan sponsors that elect to cover these drugs. In its words: "CVS Caremark will add Zepbound back to our commercial formularies as an additional preferred option October 1, 2026, increasing access to GLP-1s at a more affordable price for plan sponsors who elect to provide coverage of those medications for their members." (CVS Health press release, CVS Caremark delivers affordability and access to GLP-1 weight management medications with expanded coverage options, May 28, 2026, cvshealth.com, read Nov 17, 2026). Plan sponsors that use CVS Caremark's template formularies can still customize what they cover. In its words: "Plan sponsors that adopt CVS Caremark template formularies retain discretion to customize coverage for their members." (CVS Health press release, CVS Caremark delivers affordability and access to GLP-1 weight management medications with expanded coverage options, May 28, 2026, cvshealth.com, read Nov 17, 2026). CVS Caremark preferred Wegovy and removed Zepbound from its commercial template formularies on July 1, 2025. In its words: "to prefer Wegovy and remove Zepbound. We’re confident our decision to prefer Wegovy on our commercial template formularies will enable wider, more affordable coverage for weight management drugs, while preserving clinical integrity." (CVS Health, Improving access and affordability to high-cost weight management drugs, June 27, 2025, cvshealth.com, read Nov 17, 2026). Wegovy not covered: the cash price at your dose
Does CVS Caremark cover Zepbound for sleep apnea?
CVS Caremark's supplemental-indications criteria approve Zepbound for moderate to severe obstructive sleep apnea with an AHI of at least 15 per hour and a current BMI of 30 or more. In its words: "The patient has an established diagnosis of moderate to severe OSA with an apnea-hypopnea index (AHI) of at least 15 events per hour on polysomnography (PSG) or home sleep apnea test (HSAT) with a technically adequate device. [ACTION REQUIRED: Documentation is required for approval.] The patient has a current body mass index (BMI) greater than or equal to 30 kg/m2." (CVS Caremark criteria 6410-C, Anorexigenic Agents Supplemental Indications Only PA with Limit (P08-2025 v6, copyright 2026), info.caremark.com, read Nov 17, 2026).
Does CVS Caremark cover Wegovy for heart disease?
The same criteria approve Wegovy to reduce major cardiovascular events in adults with established cardiovascular disease and obesity or overweight (baseline BMI 27 or more, no type 2 diabetes). In its words: "Authorization may be granted when the requested drug is being used to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction (MI), or non-fatal stroke) in an adult with established cardiovascular disease AND either obesity or overweight when ALL of the following criteria are met:" (CVS Caremark criteria 6410-C, Anorexigenic Agents Supplemental Indications Only PA with Limit (P08-2025 v6, copyright 2026), info.caremark.com, read Nov 17, 2026).
What do Zepbound and Wegovy cost if CVS Caremark does not cover them?
Zepbound costs $299/28 days at 2.5 mg and $449/28 days at 15 mg without insurance at Amazon Pharmacy and LillyDirect (Eli Lilly), checked Nov 11, 2026 on pharmacy.amazon.com and zepbound.lilly.com. At 15 mg, the terms: at Amazon Pharmacy, through Dec 31, 2026, with Lilly's self-pay card, whose terms on Lilly's Zepbound savings page say "Card expires and savings end on 12/31/2026" and require each refill within 45 days of the previous delivery, or Lilly's regular $699 applies; at LillyDirect (Eli Lilly), Self Pay Journey price with a refill within 45 days; otherwise $499 at 7.5 mg or $699 at 10 to 15 mg. Wegovy costs $199/28 days, through Dec 31, 2026 at 0.25 mg and $349/28 days at 2.4 mg without insurance at Amazon Pharmacy and NovoCare (Novo Nordisk), checked Nov 11, 2026 on pharmacy.amazon.com and novocare.com. Compounded, not FDA-approved: compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year with the membership); compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year with the membership). Every GLP-1's cash price without insurance
Does Medicaid cover Zepbound or Wegovy?
It depends on the state: 10 state programs cover GLP-1s for weight loss, by KFF's January 2026 map and the states' own notices since. Every state's Medicaid answer
GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.